Oneness Biotech Co

Oneness Biotech Co Current Assets

The Current Assets of Oneness Biotech Co (4743.TWO) as of Nov 5, 2026 is 192.05 M TWD. In the previous year, Current Assets was 274.21 M TWD — a change of -29.96% (lower).

Current Assets

192.05 MTWD

YoY

-29.96%

Last updated:

Current Assets of Oneness Biotech Co is 2025 192.05 M TWD. Current Assets of Oneness Biotech Co was 2024 274.21 M TWD. It decreases by -29.96% lower compared to the previous year.

The Oneness Biotech Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
745.18 M TWD
Jan 1, 2019
1.69 B TWD
Jan 1, 2020
8.94 B TWD
Jan 1, 2021
8.05 B TWD
Jan 1, 2022
8.23 B TWD
Jan 1, 2023
8.02 B TWD
Jan 1, 2024
274.21 M TWD
Jan 1, 2025
192.05 M TWD
The Oneness Biotech Co Current Assets history
YEARCurrent AssetsYoY
192.05 MTWD-29.96%
274.21 MTWD-96.58%
8.02 BTWD-2.61%
8.23 BTWD+2.26%
8.05 BTWD-9.91%
8.94 BTWD+429.30%
1.69 BTWD+126.59%
745.18 MTWD-39.78%
1.24 BTWD-21.15%
1.57 BTWD-15.09%
1.85 BTWD+48.46%
1.24 BTWD+7.98%
1.15 BTWD+50.88%
764.07 MTWD+48.57%
514.29 MTWD-36.33%
807.70 MTWD-4.52%
845.95 MTWD+56.37%
540.98 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oneness Biotech Co Stock analysis

What does Oneness Biotech Co do? Oneness Biotech Co., Ltd. generates revenue through the research and development of new drugs and the sale of pharmaceutical products and health products. The company focuses on health supplies, health food, and healthy food as its main products, which are distributed domestically. It also develops new drugs for treating chronic diabetic foot ulcers and anticancer drugs, targeting the domestic market for both its existing and new product lines. The firm's primary customers are domestic consumers seeking health and pharmaceutical solutions, including those requiring wound healing treatments for diabetic foot ulcers and anticancer therapies. Its product portfolio includes health supplies, health food, healthy food, and specialized drug developments, all sold within Taiwan's domestic market. Oneness Biotech's business model centers on developing and selling health and pharmaceutical products, with a particular emphasis on niche medical applications like diabetic foot ulcer treatments and cancer drugs. The company leverages its domestic distribution network to reach consumers interested in health-focused solutions and specialized medical treatments. Oneness Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oneness Biotech Co stock

Current Assets of Oneness Biotech Co is 192.05 M TWD in 2025.

Current Assets of Oneness Biotech Co changed from 274.21 M TWD to 192.05 M TWD, representing a -29.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Oneness Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Oneness Biotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Oneness Biotech Co

All Key Metrics — Oneness Biotech Co